Indiana University researchers are collaborating on a novel approach to use neuroimaging and network modeling tools-;previously developed to analyze brains of patients in the clinic-;to investigate Alzheimer’s disease progression in preclinical animal models.
COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights – Psychedelic Alpha
LONDON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Highlights: COMP360 Phase 3 pivotal program ongoing and on track CPT® III code for in-person psychedelic therapy support